This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Richard A. Baxter, M.D., Receives OR Excellence Award For Use Of EXPAREL®

Stocks in this article: PCRX

Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that prominent Seattle-based plastic surgeon Richard A. Baxter, M.D., FACS was recognized by Outpatient Surgery magazine for his use of EXPAREL ® (bupivacaine liposome injectable suspension) for postsurgical pain management. The award for “Best Use of Opioid Alternatives” will be presented during the OR Excellence Conference in Fort Lauderdale, Fla. from October 17 to 19.

An early adopter of EXPAREL, Dr. Baxter has been using the non-opioid local analgesic for several months to control postsurgical pain in patients undergoing abdominoplasty and breast augmentation procedures, which he says has reduced his opioid use by at least 50 percent.

“It has always been important to me to stay on the cutting edge of any advances that can help improve my patients’ postsurgical experience and control their discomfort during the healing process,” said Dr. Baxter, owner and medical director of Richard A. Baxter Plastic Surgery Clinic. “As we know, opioids are effective analgesics, but their associated side effects can pose multiple issues during the recovery process. I have used EXPAREL in more than 35 cases to date and my patients are in remarkably less discomfort, taking fewer opioids and are comfortable enough to begin to ambulate much sooner than we have previously seen.”

Also at the OR Excellence conference, Eugene R. Viscusi, M.D., anesthesiologist and director of acute pain management at Thomas Jefferson University in Philadelphia, will speak on emerging options in non-opioid analgesia in a CME presentation.

“As an anesthesiologist and pain specialist, I recognize that pain management begins both before and during the anesthetic - not just after the operation,” said Dr. Viscusi. “Although they can be effective analgesics, opioids have problematic side effects. I always try to minimize reliance on opioids with a foundation of non-opioid analgesics such as local anesthetics, like EXPAREL; acetaminophen; and non-steroidal anti-inflammatory agents.”

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,778.15 +421.28 2.43%
S&P 500 2,061.23 +48.34 2.40%
NASDAQ 4,748.3960 +104.0840 2.24%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs